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In Vivo Measurement of Transverse Relaxation Time
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Purpose: To establish regional T1 and T2 values of the healthy
mouse brain at ultra-high magnetic field strength of 17.6 T and
to follow regional brain T1 and T2 changes with age.
Methods: In vivo T1 and T2 values in the C57BL/6J mouse
brain were followed with age using multislice-multiecho
sequence and multiple spin echo saturation recovery with vari-
able repetition time sequence, respectively, at 9.4 and 17.6 T.
Gadolinium-tetra-azacyclo-dodecane-tetra-acetic acid phan-
toms were used to validate in vivo T2 measurements. Student’s
t-test was used to compare mean relaxation values.
Results: A field-dependent decrease in T2 is shown and
validated with phantom measurements. T2 values at 17.6 T
typically increased with age in multiple brain regions except in
the hypothalamus and the caudate-putamen, where a slight
decrease was observed. Furthermore, T1 values in various
brain regions of young and old mice are presented at 17.6 T. A
large gain in signal-to-noise ratio was observed at 17.6 T.
Conclusions: This study establishes for the first time the nor-
mative T1 and T2 values at 17.6 T over different mouse brain
regions with age. The estimates of in vivo T1 and T2 will be useful
to optimize pulse sequences for optimal image contrast at 17.6
T and will serve as baseline values against which disease-related
relaxation changes can be assessed in mice. Magn Reson Med
70:985–993, 2013. VC 2012 Wiley Periodicals, Inc.
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INTRODUCTION
Transverse (T2) and longitudinal (T1) relaxation times play
an important role in optimizing magnetic resonance imag-
ing (MRI) parameters [e.g., contrast level, signal-to-noise
ratio (SNR)] and provide a quantitative indicator of tissue
changes induced by various pathological conditions (1,2).
The changes in T2 values of the brain tissue are widely
used as a surrogate marker in the evaluation of various
brain disorders (3,4). The in vivo T2 of brain tissue is
related to the local water environment and the free-to-
bound water ratio, which may change in response to cellu-
lar and axonal loss or membrane breakdown (5–8). For
example, the process of breakdown of myelin in certain
types of neurodegenerative disorders, such as multiple
sclerosis and Alzheimer’s disease, leads to alterations in
the local water environment that increase the ratio of the
free-to-bound water in tissue and thus increases T2 and T1
of white matter (5,9,10). The T2 and T1 also change in
brain regions where brain iron is deposited in the form of
ferritin and hemosiderin (11). In addition, both T1 and T2
values provide quantitative information about tissue
changes in the healthy brain during aging (12,13).
Mice are routinely used as models for studying
human brain disorders. Due to the small size of the
mouse brain, the present trend in in vivo mouse brain
MRI is to move toward ultra-high magnetic field (7 T)
for improved SNR, higher resolution, sensitivity, and
specificity (14–18). Thus, ultra-high magnetic field sys-
tems, such as 17.6 T, can serve as a powerful tool to
detect more subtle abnormalities in anatomical and
functional characteristics of emerging mouse models of
neurodegenerative diseases (19). Although the values
for T2 relaxation time in different parts of the mouse
brain have been published in different field strengths
(2,12,20–23), there is no systematic assessment of the
regional T2 values for the healthy mouse brain at 17.6
T. The values of T1 relaxation time of various mouse
brain regions have been reported at 17.6 T in young
mice (18). However, age-dependent changes in T1 have
not been analyzed at this magnetic field strength. The
C57BL/6J mouse is one of the most widely used inbred
strains and the first to have its genome sequenced (24).
It is generally used as a background strain for the gener-
ation of transgenic models of various brain diseases
such as Alzheimer’s disease (19). In this study, we
aimed to establish the values of regional T2 relaxation
time for healthy C57BL/6J mouse brain in vivo at 17.6 T
and to determine magnetic field dependent changes in
T2. Phantom solutions were used to validate changes in
T2 at different field strengths and to explore the validity
of multislice-multiecho (MSME) sequence to measure
T2. In addition, we assessed age-related regional T2 and
T1 changes in the mouse brain at 17.6 T. These esti-
mates of in vivo T2 and T1 relaxation of the mouse brain
will be useful to optimize MRI sequences for optimal
image contrast and sensitivity in the mouse brain at
17.6 T. In addition, knowledge of age-related T2 and T1
changes in the healthy mouse brain is mandatory, if dis-
ease-related deviations in T2 and T1 have to be studied
in longitudinal studies.
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METHODS
Phantoms
Phantom solution containing different concentrations of
Gadolinium-tetra-azacyclo-dodecane-tetra-acetic acid
(Gd-DOTA) (Dotarem; Guerbet Nederland BV, Gori-
nchem, The Netherlands) was prepared by diluting a
stock solution of Gd-DOTA (0.5 M) in phosphate buffer
saline (pH 7.50). Dilution factors used for T2 measure-
ments were 1/50 (i.e., 10 mmol Gd-DOTA/L), 1/100, 1/
200, 1/400, 1/800). The same phantoms were used for
both MRI and nuclear magnetic resonance (NMR) experi-
ments. For the SNR analysis, the phantom solution con-
sisting of 20% H2O, 80% D2O, and 1 g L
1 copper sul-
fate (CuSO4) was prepared.
High-Resolution NMR
High-resolution NMR experiments were performed at
2.35, 9.4, and 17.6 T magnets using a broadband 5-mm
solution-state NMR probe. Radiation damping was mini-
mized using a restricted sample volume (capillary NMR
tubes) in low-Q probes. The pulse sequence used for T2
measurements was based on the Carr–Purcell–Meiboom–
Gill (CPMG) scheme. The pulse lengths of 90 and 180 at
all fields were 9.6 and 19.2 ms, respectively. A variable
list of 16 duration times between 90 and 180 pulse was
adopted. Both the recycle delay and the longest duration
time were kept at larger than 10 times of the expected T2
of each sample.
Mice
For all in vivo measurements, female C57BL/6J mice
were used. All the animal experiments were approved
by the Institutional Animal Care and Animal Use Com-
mittee of the University of Leiden in accordance with
the NIH Guide for the Care and Use of Laboratory
Animals.
MRI
All MRI measurements were performed using 400 MHz
(9.4 T) and 750 MHz (17.6 T) vertical 89-mm bore mag-
nets equipped with a 1 T m1 actively shielded imaging
gradient insert (Bruker, Germany). A birdcage radiofre-
quency (RF) coil with an inner diameter of 2 cm was
used for excitation and detection. The system was inter-
faced to a Linux PC running Topspin 2.0 and ParaVision
5.0 software (Bruker Biospin GmbH, Germany).
All in vivo MRI studies were conducted as previously
described (25). Before imaging, the mice were initially
anesthetized with 2% isoflurane (Forane, Abott, UK), in
air (0.3 L min1) and oxygen (0.3 L min1). During scan-
ning, the level of anesthetic was maintained between 1
and 1.5% to keep the breathing of the animal at a con-
stant rate of 50 breaths min1. Animals were placed in
the 20-mm birdcage RF coil with a special mouse head
mask, which was used to administer the anesthetic gas
during the MR experiments. A respiration sensor, con-
nected to a respiration unit, was placed on the abdomen
to monitor respiration rate. The respiration unit was con-
nected to a computer having Bio-SAM respiration moni-
toring software (Bruker Biospin, Germany). During MRI
imaging, the respiration rate of the mouse was constantly
monitored, and the body temperature of the mouse was
kept constant by pumping warm water (30 6 1C)
through the gradient system. The rectal body temperature
of the mouse during scanning was measured to be 30 6
1C. T2 measurements in phantom solutions were also
conducted at 30 6 1C and were repeated at least four
times.
T2 values were measured with the MSME sequence
that is based on the CPMG sequence, where transverse
magnetization of a 90 pulse is refocused by a train of
180 pulses generating a series of echoes (26,27). The fol-
lowing imaging parameters were used for the phantom
and in vivo experiments both at 9.4 and 17.6 T: number
of averages ¼ 2; number of slices ¼ 1 and/or 10 with a
slice thickness of 1.0 mm and an interslice thickness of
1.5 mm; number of echoes ¼ 16 with echo spacing ¼
8.5; a repetition time (TR) ¼ 3 s with an effective spec-
tral bandwidth ¼ 50 kHz; field of view (FOV) ¼ 2.0 
2.0 cm2; and matrix size¼ 256  256; this yields an
effective in in-plane resolution of 0.078  0.078 mm2
and a voxel resolution of 6.10  103 mm3. The total ac-
quisition time for the experiment was 19 min 12 s. To
study the dependence of T2 on the CPMG refocusing
interpulse interval (t), the T2 measurements were per-
formed using the MSME sequence with 16 echo and 4
different refocusing interpulse intervals, namely 5.6, 8.5,
10, and 18 ms. The last 5 echo of 8.5 ms acquisition, the
last 7 echo of 10 ms acquisition, and the last 10 echo of
18 ms acquisition were discarded to provide comparable
temporal sampling windows (namely, 5.6–91.04, 8.5–
93.50, 10–90, and 18–90 ms acquisitions, respectively).
For the precise localization of regions of interest (ROIs)
on the brain regions for T2 measurements, a pilot scan of
a mouse brain was acquired with multislice rapid acqui-
sition using the relaxation enhancement (RARE)
sequence (28), and subsequently ROIs were transferred
to T2 maps to ensure precise regional placement. The fol-
lowing imaging parameters were used for the RARE
sequence: echo time (TE) ¼ 11.67 ms (at 9.4 T) and 8.5
ms (at 17.6 T); TR ¼ 1500 ms (at 9.4 T) and 2000 ms (at
17.6 T); number of averages ¼ 1, rare factor ¼ 6; number
of slices ¼ 10, with slice thickness 1.0 mm; and inter-
slice thickness ¼ 1.5 mm. To establish the test–retest
reliability of T2 measurements, the same mice (n ¼ 7)
were scanned twice with an interval of 4 days, and the
phantom solution (10 mM) was scanned twice with an
interval of 6 weeks. For the measurement of the SNR in
the phantom solution, the mic-MSME sequence (Bruker,
Paravision 5) was used. The following imaging parame-
ters were applied both at 9.4 and 17.6 T: TE¼ 7 ms, TR
¼ 1000 ms, number of averages ¼ 1, FOV ¼ 6.0  6.0,
matrix ¼ 256  256, slice thickness ¼ 1 mm, and num-
ber of slices ¼ 11.
T1 was measured with a multiple spin echo saturation
recovery method with variable TR (RAREVTR). Slice ex-
citation and refocusing were accomplished by hermite
pulses, resulting in 90 and 180 pulse lengths of 1.4 and
0.9 ms, respectively. The following imaging parameters
were used at 17.6 T: TE ¼ 5.5 ms; TR-array ¼ 0.1, 0.18,
0.36, 0.6, 0.8, 1.0, 1.5, 2.0, 4.0, 6.0, 10.0, and 15.0 s;
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matrix size¼ 128  128; FOV ¼ 1.7  1.7 cm2; and slice
thickness ¼ 0.9 mm. The total acquisition time for the
experiment was 33 min 13 s. All images acquired single
slices to prevent interslice modulation effects. The slice
was positioned as described previously (18). To mini-
mize the contribution of partial volume effect from cere-
brospinal fluid, the ROIs were checked carefully on
images collected with very thin slices (0.25 mm) using
the same RAREVTR sequence with following parameters:
TR ¼ 6000 ms, TE ¼ 17 ms, FOV ¼ 1.5  1.5 cm, matrix
size ¼ 256  256, and number of slices ¼ 10.
For the comparison of the SNR for in vivo imaging at
two different magnetic field strengths (9.4 and 17.6 T),
the experiment was performed with the RAREVTR
sequence using three different TR (6, 10, and 15 s) and
TE (5.5, 16.5, and 27.5 ms). The following imaging pa-
rameters were used: number of averages ¼ 1; TR-array ¼
15,000, 10,000, 6000; TE ¼ 5.5, 16.5, 27.4 ms; FOV ¼ 1.7
 1.7 cm2; matrix size¼ 128  128; slice thickness ¼ 0.6
mm; and effective spectral bandwidth ¼ 71,428 kHz. The
same mouse was used for SNR measurements at 9.4 and
17.6 T.
Data Processing
Estimation of T2 and T1
To calculate T2, ROIs were drawn on the images using
an image sequence analysis tool package (Paravision 5,
Bruker), which uses a fit function [y ¼ A þ C * exp(t/
T2)], where A ¼ absolute bias, C ¼ signal intensity, and
T2 ¼ transverse relaxation time. The T1 values were
determined by image sequence analysis using a fit func-
tion: M(t) ¼ A þ M0 * (1  exp(t/T1), where M0 is the
equilibrium magnetization. ROIs were manually defined
for the hippocampus (HC), cortex (CX), thalamus (TH),
hypothalamus (HT), corpus callosum (CC), caudate-puta-
men (Cpu), olfactory bulb (OB) and its glomerular layer
(GL), and muscle (M), using the ‘‘Allen Brain Atlas’’ with
the brain explorer program (http://mouse.brain-map.org)
as the reference atlas. For all animals, the T2 and T1
were the mean of the ROIs drawn on the right and left
sides of the brain, except for the CC region. For phan-
toms, a cylinder was drawn on the inside of the axial fig-
ures of the tubes. The transverse relaxation rate (R2) was
obtained from the equation: R2 ¼ 1/T2 (s1). Relaxivity of
the contrast agent is defined as the efficiency by which
an MRI contrast agent can accelerate the proton relaxa-
tion rate in a homogeneous medium (29). Relaxivity (r2)
was calculated as the slope of the linear regression line
of a plot of R2 vs. concentration of MRI contrast agent
(30).
Estimation of SNR
The SNR in the images is measured as the average signal
intensity over the ROI divided by the standard deviation
of the noise.
Statistics
A paired and/or two-tailed Student’s t-test was used to
compare mean values. Statistical significance was
assigned for values of P < 0.05. The reliability of the
measurements was assessed by computing the intraclass
correlation coefficient (ICC2,1) using a two-way random
effects analysis of variance (ANOVA) model and the
absolute agreement definition (31,32). The associations
between test and retest data were analyzed by the Pear-
son’s correlation coefficient (r) at a 0.05 significance
level. An ICC close to 1 indicates excellent reliability.




Figure 1a depicts the quantitative relaxivity (r2) of Gd-
DOTA phantom solutions at 17.6 T using MRI and high-
resolution NMR methods. The MSME and the single-
slice-multiecho MRI methods showed 11 and 8% lower
r2 values, respectively, relative to the value acquired
with the NMR method. Figure 1b shows the r2 of Gd-
DOTA phantom solutions determined at 2.35, 9.4, and
17.6 T using the high-resolution NMR method. As is
clear from this figure, plots of the transverse relaxation
rate, R2 (1/T2), vs. the Gd-DOTA concentration (mM)
reveal a linear dependence of the R2 on the
FIG. 1. a: Scatter plots showing the changes in relaxation rates (R2) as a function of the Gd-DOTA concentration measured using MRI
and NMR at 17.6 T. b: Scatter plots showing the changes in R2 as a function of magnetic field strength (2.35, 9.4, and 17.6 T) measured
using NMR. Mean R2 in s
1 6 error bars (SEM: standard error of the mean). The slopes of the weighted linear regression curves are the
T2 relaxivities (r2). r2 in mM
1 s1 6 SEM; MRIm, multislice-multiecho MRI; MRIS, single-slice-multiecho MRI. The correlation coefficient
(Pearson’s r) of the linear fitting for all lines is 0.99.
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concentration. In addition, the r2 values increased with
increasing field strength. The value of r2 at 17.6 T is
18% and at 9.4 T is 11% higher relative to the value
at 2.35 T. These results clearly show that T2 relaxation
times of Gd-DOTA decrease with increasing field
strength.
To confirm that the 180 pulses in the MSME sequence
did not introduce spurious magnetization from stimulated
echoes or from signals originating from outside the
selected slices, T2 decay curves from a Gd-DOTA phantom
with echo spacings of 8.5, 13, 15, and 17 ms were
acquired. An example of a T2 decay curve with an 8.5
echo spacing is depicted in Figure 1S-a (Supporting Infor-
mation). The differences among T2 values acquired using
the various echo spacings were statistically insignificant.
To observe the variation of the T2 between the 10 slices
used in the multiecho sequence, the T2 of the phantom (10
mM) was measured for each slice. No statistically signifi-
cant variation in T2 values was observed between the sli-
ces (P > 0.05) (Fig. 1S-b). To assess the test–retest reliabil-
ity of the Gd-DOTA phantom, T2 data were acquired at
17.6 T using the MSME sequence at two different time
points, separated by an interval of 46 days. The differen-
ces in mean T2 values between two sessions were statisti-
cally insignificant, with P > 0.05. The ICC and Pearson’s r
values were measured as 0.92 and 0.97, respectively, sug-
gesting superior test–rest reliability (P < 0.05 in all cases)
and minimum instrumental variations. The SNR perform-
ance at both magnetic field strengths was compared and
was found to increase by a factor of 1.5 at 17.6 T as com-
pared to 9.4 T.
In Vivo Studies
Figure 2a shows ROIs that were selected on a representa-
tive series of RARE images from a normal mouse to ac-
quire T2. Figure 2b depicts a graphical summary of the in
vivo T2 relaxation times in the mouse brain, at 9.4 and
17.6 T. A clear decrease in T2 values was observed in vari-
ous brain regions at 17.6 T as compared to 9.4 T. However,
the T2 in the muscle showed a relatively small decrease at
17.6 T as compared to 9.4 T. At both magnetic field
strengths, the T2 were the longest for the OB and the grill
regions, whereas the TH and the CC consistently show a
shorter T2 compared with other brain regions. Table 1
depicts the quantitative summary of the in vivo T2 of the
mouse brain at 9.4 and 17.6 T. To validate the in vivo T2
dataset that was acquired using a multislice mode, the
measurement was repeated in the single-slice mode. The
T2 values measured using multislice mode were slightly
higher than those from the single-slice mode (Fig. 2S, Sup-
porting Information); however, the systematic overestima-
tion was less than 3 ms. The SNR of the CX region of the
mouse brain at both magnetic field strengths was com-
pared and was found to increase by a factor of 1.6 at 17.6 T
as compared to 9.4 T. The dependence of CX and CC T2 on
the CPMG refocusing interpulse interval (t) was investi-
gated at 17.6 T (Fig. 3S, Supporting Information). No stat-
istically significant effect of interpulse interval in the
range of interest (between 5.6 and 18 ms) was observed on
T2 of CX and CC.
Table 2 shows test–retest reliability results of in vivo
T2 measurements in multiple brain regions. The ICCs
were statistically significant (P < 0.05) for all regions.
The test–retest reliability was very good for CX, TH, CC,
Cpu, as well as muscle tissue, with the ICC ranging
between 0.84 and 0.92. For HC and HT, ICC was 0.64
and 0.53, respectively. Table 2 also presents Pearson’s r,
which showed superior association for all regions
between two sessions. For all the brain regions, Pear-
son’s r was statistically significant (P <0.05). However,
Pearson’s r for HT regions was somewhat less than for
the other regions (P ¼ 0.062). The systematic error
was checked by a paired t-test, and results are shown
in Table 2.
Figure 3 summarizes the age-related changes of the T2
for the mouse brain at 17.6 T. The in vivo T2 increases
with age for multiple brain regions except the HT and
the Cpu, where a slight decrease in T2 was observed. A
significant increase in T2 was observed in the CX region
in 13.6- and 15.1-month-old mice as compared to 3.6-
month-old mice (Table 3).
Table 4 depicts the T1 values in multiple mouse brain
regions in young (3 months old) and old (23 months old)
mice at 17.6 T. No significant changes in T1 were
observed between young and old mice in various brain
regions except slightly shorter T1 in the CC and the Cpu,
and slightly longer T1 in TH regions were observed in
old mice as compared to young mice.
DISCUSSION
Phantom Studies
The r2 acquired with the MSME sequence was in very
close agreement with the values obtained using high-
resolution NMR method and the r2 derived from the data
collected with the single-slice-multiecho sequence. The
results validate the accuracy of the T2 extracted from the
data acquired with the MSME sequence at 17.6 T. In
addition, phantom experiments showed that r2 decreases
with increasing magnetic field strength. The apparent
FIG. 2. a: MR coronal slices of a mouse brain, showing relevant
ROIs, acquired with the RARE sequence at 17.6 T. b: In vivo T2
relaxation times of different mouse brain regions acquired at 9.4
and 17.6 T. The analyzed brain structures include the HC, CX, TH,
HT, CC, Cpu, OB, GL of OB; muscle (M, internal reference). Val-
ues are expressed as mean T2 in ms 6 SEM (error bars). Two-
tailed Student’s t-test, P < 0.05 in all regions; n ¼ 5.
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decrease of the T2 with increasing field strength is
incompatible with straightforward Bloembergen–Purcell–
Pound model dipolar relaxation processes that would
lead to a T2 that is independent of the field strength
(14,33). A decrease of the T2 with increasing field
strength can be attributed to increasing microscopic sus-
ceptibility gradients, causing irreversible dephasing due
to diffusion across those gradients (34–36). The MSME
method used in this study to acquire T2 data is time-
effective, because the sequence allows for imaging sev-
eral slices in a single scan (37,38). Previous studies,
however, have reported that many factors, such as spuri-
ous echoes, can influence the ability to obtain accurate
T2 data using the MSME method (37–42). Moreover,
there are additional concerns regarding the effect of
higher magnetic field strength including: magnetic field
inhomogeneity, increased stimulated echo artifacts, and
increased power deposition (43). We have demonstrated
that the 180 pulses in the MSME sequence introduce no
spurious magnetization contribution from stimulated
echoes, because the estimated T2 values for the phantom
did not change significantly for echo spacings of 8.5, 13,
15, and 17 ms. Also spatially uniform T2 was observed
throughout the 10 slices suggesting that the performance
of the 180 refocusing trains was spatially uniform for
the MSME sequence (Fig. 1S-b, Supporting Information).
Furthermore, excellent test–retest T2 reliability was
measured by the MSME sequence. These results sug-
gested that there is no evidence of contamination of T2
via spurious echoes, and the instrumental variation was
negligible at 17.6 T.
A higher SNR was observed for the phantom and the
mouse brain at 17.6 T as compared to 9.4 T. If the relaxa-
tion parameters are ignored, the SNR is expected to
increase linearly with magnetic field strength (14). The
SNR has been reported to be proportional to magnetic
field strength (B0) and the square root of (T2/T1) in a
fully relaxed pulse [SNR ! B0HT2/T1] (14). The lower-
than-predicted increase in SNR at 17.6 T could be
related with many factors such as changes in relaxation
times (shorter T2 and longer T1), increased susceptibility
effects, and larger field inhomogeneity (44,45). All these














































































































































































































































































































FIG. 3. In vivo T2 relaxation times of the mouse brain with age
measured at 17.6 T. The analyzed brain structures include the HC,
CX, TH, HT, CC, and Cpu. Values are expressed as mean T2 in
ms 6 SEM (error bars); n ¼ 5. Paired t-test, *P < 0.05, significant
from T2 at 3.6 months (M). Same mice were scanned at the age
of 3.6, 13.6, and 15.1 months.
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addition, it has been reported that experimental condi-
tions such as RF coils, pulse sequences, and preampli-
fiers also affect the SNR quantification (46).
In Vivo Studies
In this study, the in vivo T2 for several regions of the
healthy mouse brain have been presented at 17.6 T.
Although the T2 in different parts of the transgenic and
nontransgenic mouse brain have been published for dif-
ferent field strengths (2,12,20–23), and T2 maps of the is-
chemic mouse brain were provided at 17.6 T, a system-
atic assessment of the T2 for the healthy mouse at 17.6 T
was not yet obtained. Our results at 17.6 T are well in
line with data from healthy rat brain acquired at 16.4 T
(47). In addition, the in vivo T2 of the mouse brain deter-
mined at 9.4 T in this study reproduces well with earlier
published data (2,12,20,22). In particular, the T2 values
of the CC, HC, and Cpu are in excellent agreement with
earlier report at 9.4 T (20). Our results also illustrate that
T2 decreases in various brain regions with increasing
magnetic field strength and are consistent with earlier
reports (14,36,43,48,49), although the extent of T2 reduc-
tion was found to be dependent on the composition of
the tissue. The T2 of the muscle tissue did not show a
strong field dependence, which could be attributed to
the lower intracellular molecular mobility of the water in
the muscle tissue than for the brain tissue. The decrease
of tissue T2 with increasing magnetic field strength has
been explained in terms of the molecular processes of
diffusion and/or chemical exchange of spins between
regions with different magnetic field strengths
(34,36,50,51). Magnetic field inhomogeneities increase
linearly with increasing magnetic field strength and are
created by local susceptibility gradients, which can be
microscopic (e.g., surrounding blood vessels) as well as
macroscopic (e.g., around the sinuses and petrous bone)
(34). Diffusion across these magnetic field gradients
dephases the transverse magnetization of the water pro-
tons, resulting in an overall decrease of the T2. The mag-
nitude of these gradients increases with field strength,
and therefore, their effect on T2 increases with the mag-
netic field strength (14). This process is referred to as
dynamic dephasing, and it depends, among other things,
on the refocusing interpulse interval (t) defined as half
the interval between successive 180 pulses in a CPMG
sequence (11,36,52). It has been shown, in theory and
experiments, that T2 decreases with increasing t
(11,36,52,53). Several works have investigated the effect
of varying t on T2 measurements in biological tissues
(11,51,52,54,55). In our experiments, to obtain an esti-
mate of the effect that the refocusing interpulse interval
has on T2, we repeated the T2 measurements with four
different t values, between 5.6 and 18 ms (Fig. 3S, Sup-
porting Information). No statistically significant depend-
ence of the T2 on the interpulse interval was observed.
This result suggests that the changes observed in T2 val-
ues with age depend more on changes in tissue proper-
ties in the individual brain structures rather than mag-
netic field disturbances. In our study, a relatively short
refocusing interpulse interval (8.5 ms) was used. How-
ever, even in these conditions, contribution of diffusion
and/or chemical exchange on T2 is inevitable. In prac-
tice, most studies are performed with t values no shorter
than those used here, and thus, for optimization of con-
trast and general clinical applications, the T2 values
Table 2
Test–Retest Reliability Results of In Vivo T2 Relaxation in Various Mouse Brain Regions at 17.6 T
Structure
Mean 6 SEM
ICC2,1 r Paired t-testSession 1 Session 2
CX 28.11 6 0.14 28.01 6 0.15 0.92 0.95 ns
HC 28.24 6 0.21 27.97 6 0.14 0.64 0.79 ns
TH 26.09 6 0.18 25.90 6 0.16 0.84 0.91 ns
HT 26.28 6 0.18 25.79 6 0.30 0.53 0.73 ns
CC 26.43 6 0.44 26.37 6 0.30 0.82 0.86 ns
Cpu 26.47 6 0.20 26.27 6 0.21 0.84 0.88 ns
OB 27.50 6 0.27 27.25 6 0.24 0.90 0.97 <0.05
GL 27.56 6 0.24 27.22 6 0.21 0.83 0.96 <0.05
M 21.47 6 0.22 21.37 6 0.21 0.90 0.90 ns
ICC ¼ intraclass correlation using a two-way random effects ANOVA (subject by session) and the absolute agreement, P < 0.05 in all
cases for ICC, r ¼ Pearson correlation coefficient, P < 0.05 in all cases for r except for HT, where P ¼ 0.062, T2 (ms) means from seven
subjects, SEM ¼ standard error of the mean, paired t-test ¼ session 1 and session 2 results collected from the same mice were com-
pared. P > 0.05 in all cases for paired t-test except for OB and GL, where P < 0.05. There is four-day interval between session 1 and
session 2.
Table 3
In Vivo T2 Values of the Mouse Brain with Age at 17.6 T
Age (months) HC CX TH HT CC Cpu M
3.6 27.84 6 0.10 27.70 6 0.16 25.83 6 0.08 26.64 6 0.41 25.73 6 0.08 26.96 6 0.13 21.25 6 0.44
13.6 28.06 6 0.24 28.20 6 0.15* 26.03 6 0.26 26.15 6 0.23 26.17 6 0.48 26.42 6 0.29 21.53 6 0.31
15.1 28.60 6 0.38 28.38 6 0.10* 26.06 6 0.28 26.28 6 0.23 26.28 6 0.53 26.55 6 0.27 21.23 6 0.16
Values are expressed as mean relaxation times (ms 6 standard error of the mean), n ¼ 5. M ¼ muscle.
*Paired two-tailed t-test: P < 0.05 compared to mice at the age of 3.6 months.
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represented here are expected to be valid and reproduci-
ble under similar experimental conditions across
platforms.
In our study, age-dependent changes in T2 in multiple
brain regions, including the CX, HC, TH, and CC were
observed at 17.6 T (Fig. 3 and Table 3). In particular, in
CX T2 relaxation time shows a significant increase with
age. These results are in good agreement with a recently
published age-dependent T2 measurement in human
brain at 3 T (13). T2 values of the brain tissue can
increase with age in response to cellular and axonal loss
or membrane breakdown (5,56,57). These aging processes
reduce the number of macromolecules and increase free
water content and thus raising the ratio of free-to-bound
water protons and as a result contributing to the increase
in T2 values (13). The lower T2 values in the younger
mice as compared to the older mice might also be caused
by the increased susceptibility effects at 17.6 T. The
higher susceptibility effects in the younger mice due to
very high ratio of air space to brain tissue may reduce T2
values especially at higher fields (17.6 T). Nevertheless,
T2, acquired in this study using shorter interpulse inter-
val (t ¼ 8.5 ms), is in plateau region and seems to be
less sensitive to magnetic disturbances induced by local
magnetic susceptibility effects. This would also indicate
that the changes observed in T2 values with age in our
study are more dependent on tissue cellularity changes,
rather than magnetic disturbances. A few mouse brain
regions such as the HT and the Cpu show a slight
decrease in T2 values with age, which could result from
increased deposition of paramagnetic substances such as
ferritin and hemosiderin (11,58). In human, basal gan-
glia, e.g., Cpu structures show increased levels of para-
magnetic substances with age (13). Falangola et al. (22)
did not observe any age-dependency of T2 in normal
mouse brain at 7 T. Some possible explanations of the
differences in the findings can be explained by the ROI
definition, use of different imaging parameters, suscepti-
bility effects, and the field strength. Specially, the ROI
used in our study covers only the somatosensory and the
retrosplenial granular CX regions. However, in the study
of Falangola et al., the ROI covers a bigger volume, i.e.,
the ectorhinal, perirhinal, piriform, somatosensory, and
retrosplenial granular CX regions.
It is known that technical challenges such as increased
RF field inhomogeneity, increased RF power deposition,
and susceptibility effects are prevalent at higher fields
(15), which can cause errors in the measurements of T2
(39,40). However, our results show that these factors
have negligible affect on the test–retest reliability and
accuracy of the phantom and in vivo experiments.
Although the MSME sequence provides considerable
time savings compared to single-slice-multiecho
sequence, cross-talk between slices can occur (59). How-
ever, this cross-talk can be substantially decreased by
adding slice gaps between adjacent slices (60). In our
study, an interslice gap of 150% of the slice thickness
was used that substantially reduced the influence of
cross-talk between slices (60). In addition, it has been
reported that introducing gaps between neighboring sli-
ces also helps in reducing magnetization transfer effects
by increasing the resonance offset (59). A slight overesti-
mation of the in vivo T2 was observed with the MSME
sequence compared to the single-slice sequence at 17.6
T. However, the T2 of the mouse brain observed with the
MSME sequence were consistently within 3 ms of the
values acquired with the single-slice sequence for all
regions (Fig. 2S, Supporting Information).
In clinical evaluations, T2 values are often inaccurate
in absolute terms due to the systematic errors related to,
e.g., the type of curve fitting used in the analysis and the
echo train length. In clinical evaluations, however, a
good test–retest reliability of T2 and shorter scan times
are more important than absolute accuracy. The observa-
tion that the increase in T2 using the MSME sequence as
compared to the single-slice-multiecho sequence is rela-
tively small, the absence of obvious interslice variation
of T2 in multislice imaging, and good test–retest reliabil-
ity indicated that the MSME protocol can serve to find
optimal parameters for T2 weighted sequences at 17.6 T.
In addition, the MSME sequence can be safely used for
evaluation of disease progression in the mouse models of
neurodegenerative diseases at 17.6 T.
In addition to T2 values, we also measured in vivo T1
changes for a variety of brain regions in young (3 months
of age) and old (23 months of age) mice at 17.6 T. The T1
values obtained in young mice are in excellent agree-
ment with an earlier report at 17.6 T (18). Comparison of
the T1 values in multiple brain regions did not show any
significant differences in young and old mice. Except, a
slightly lower T1 was observed in the CC and the Cpu
regions in old mice as compared to young mice. These
age-dependent T1 changes are in agreement with meas-
urements in humans (at 1.5 T) and rats (at 16.4 T)
(47,61–63). In addition, we also observed a slightly
higher T1 values in TH region of old mice as compared
to young mice. An increase in TH T1 values with age has
also been reported in human at 1.5 T (63,64). The age-
related changes in T1 might reflect various physiological
processes. For example, an increase in iron content of
brain tissue can lead to a decrease in T1, whereas a
decline in the number of myelinated fibers can cause an
increase in T1 (10,11).
CONCLUSIONS
Our results provide a comprehensive and quantitative in
vivo T2 profile for various mouse brain regions at 17.6 T
and show that the T2 decreases substantially at 17.6 T
Table 4
In Vivo T1 Values of the Mouse Brain at 17.6 T
Tissue Young Old
HC 2.14 6 0.02 2.16 6 0.01
CX 2.02 6 0.02 2.07 6 0.02
TH 2.05 6 0.02 2.17 6 0.02*
CC 1.99 6 0.00 1.92 6 0.02*
Cpu 2.01 6 0.01 1.96 6 0.02*
OB 1.97 6 0.01 1.96 6 0.02
M 2.39 6 0.03 2.37 6 0.01
Mean T1 relaxation times of young (3 months) and old (23 months)
mice (s 6 standard error of the mean), n ¼ 5. M ¼ muscle.
*Two-tailed t-test: P < 0.05 compared to young mice.
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compared with 9.4 T. In addition, age-related T2 and T1
changes in the mouse brain were observed at 17.6 T,
which can provide a useful reference for comparison
with disease-related deviations in T2 and T1 relaxation
for future studies.
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